(RWAY) Runway Growth Finance - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US78163D1000
Stock: Growth Capital, Senior Loans, Technology, Healthcare, Software
Total Rating 16
Risk 64
Buy Signal -1.31
| Risk 5d forecast | |
|---|---|
| Volatility | 23.3% |
| Relative Tail Risk | -4.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.82 |
| Alpha | -29.19 |
| Character TTM | |
|---|---|
| Beta | 0.528 |
| Beta Downside | 1.053 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.68% |
| CAGR/Max DD | 0.00 |
EPS (Earnings per Share)
Revenue
Description: RWAY Runway Growth Finance March 05, 2026
Runway Growth Finance Corp. (RWAY) operates as a business development company (BDC).
The company focuses on providing senior-secured loans to late-stage and growth companies. BDCs are regulated investment companies that invest in small and mid-sized businesses.
RWAY targets specific sectors, including technology, life sciences, healthcare, information services, and select consumer services. Its investment size for senior secured loans ranges from $10 million to $75 million.
For more detailed financial analysis, consider exploring ValueRay.
Headlines to watch out for
- Technology and life sciences loan demand drives revenue
- Interest rate fluctuations impact net investment income
- Credit quality of portfolio companies affects profitability
- Regulatory changes for BDCs create compliance costs
- Economic downturns increase loan default risk
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 54.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.40 > 1.0 |
| NWC/Revenue: -13.49% < 20% (prev 0.51%; Δ -14.00% < -1%) |
| CFO/TA 0.04 > 3% & CFO 42.3m > Net Income 54.9m |
| Net Debt (435.6m) to EBITDA (54.9m): 7.93 < 3 |
| Current Ratio: 0.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.2m) vs 12m ago -5.64% < -2% |
| Gross Margin: 64.10% > 18% (prev 0.59%; Δ 6351 % > 0.5%) |
| Asset Turnover: 10.44% > 50% (prev 8.46%; Δ 1.98% > 0%) |
| Interest Coverage Ratio: -0.99 > 6 (EBITDA TTM 54.9m / Interest Expense TTM 38.2m) |
Altman Z'' -0.66
| A: -0.01 (Total Current Assets 16.0m - Total Current Liabilities 30.3m) / Total Assets 963.3m |
| B: -0.06 (Retained Earnings -56.3m / Total Assets 963.3m) |
| C: -0.04 (EBIT TTM -37.9m / Avg Total Assets 1.02b) |
| D: -0.12 (Book Value of Equity -56.0m / Total Liabilities 473.8m) |
| Altman-Z'' Score: -0.66 = B |
Beneish M
| DSRI: 1.22 (Receivables 8.04m/5.65m, Revenue 106.4m/91.0m) |
| GMI: 0.92 (GM 64.10% / 58.97%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.17 (Revenue 106.4m / 91.0m) |
| TATA: 0.01 (NI 54.9m - CFO 42.3m) / TA 963.3m) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of RWAY shares?
As of March 09, 2026, the stock is trading at USD 7.88 with a total of 374,057 shares traded.
Over the past week, the price has changed by -0.25%, over one month by -10.05%, over three months by -14.16% and over the past year by -18.81%.
Over the past week, the price has changed by -0.25%, over one month by -10.05%, over three months by -14.16% and over the past year by -18.81%.
Is RWAY a buy, sell or hold?
Runway Growth Finance has received a consensus analysts rating of 3.67.
Therefor, it is recommend to hold RWAY.
- StrongBuy: 3
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RWAY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.7 | 35.9% |
| Analysts Target Price | 10.7 | 35.9% |
RWAY Fundamental Data Overview March 08, 2026
P/E Trailing = 5.4722
P/E Forward = 5.3677
P/S = 2.0184
P/B = 0.5883
P/EG = 1.1571
Revenue TTM = 106.4m USD
EBIT TTM = -37.9m USD
EBITDA TTM = 54.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 443.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 435.6m USD (from netDebt column, last quarter)
Enterprise Value = 720.3m USD (284.7m + Debt 443.5m - CCE 7.92m)
Interest Coverage Ratio = -0.99 (Ebit TTM -37.9m / Interest Expense TTM 38.2m)
EV/FCF = 17.01x (Enterprise Value 720.3m / FCF TTM 42.3m)
FCF Yield = 5.88% (FCF TTM 42.3m / Enterprise Value 720.3m)
FCF Margin = 39.80% (FCF TTM 42.3m / Revenue TTM 106.4m)
Net Margin = 51.60% (Net Income TTM 54.9m / Revenue TTM 106.4m)
Gross Margin = 64.10% ((Revenue TTM 106.4m - Cost of Revenue TTM 38.2m) / Revenue TTM)
Gross Margin QoQ = 55.47% (prev 67.10%)
Tobins Q-Ratio = 0.75 (Enterprise Value 720.3m / Total Assets 963.3m)
Interest Expense / Debt = 2.11% (Interest Expense 9.35m / Debt 443.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -29.9m (EBIT -37.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.53 (Total Current Assets 16.0m / Total Current Liabilities 30.3m)
Debt / Equity = 0.91 (Debt 443.5m / totalStockholderEquity, last quarter 489.5m)
Debt / EBITDA = 7.93 (Net Debt 435.6m / EBITDA 54.9m)
Debt / FCF = 10.29 (Net Debt 435.6m / FCF TTM 42.3m)
Total Stockholder Equity = 501.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.39% (Net Income 54.9m / Total Assets 963.3m)
RoE = 10.94% (Net Income TTM 54.9m / Total Stockholder Equity 501.6m)
RoCE = -4.06% (EBIT -37.9m / Capital Employed (Total Assets 963.3m - Current Liab 30.3m))
RoIC = -2.99% (negative operating profit) (NOPAT -29.9m / Invested Capital 1.00b)
WACC = 4.09% (E(284.7m)/V(728.2m) * Re(7.86%) + D(443.5m)/V(728.2m) * Rd(2.11%) * (1-Tc(0.21)))
Discount Rate = 7.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -2.47%
[DCF] Terminal Value 80.82% ; FCFF base≈42.6m ; Y1≈28.0m ; Y5≈12.8m
[DCF] Fair Price = N/A (negative equity: EV 406.5m - Net Debt 435.6m = -29.1m; debt exceeds intrinsic value)
EPS Correlation: -24.25 | EPS CAGR: -42.68% | SUE: -4.0 | # QB: 0
Revenue Correlation: 43.94 | Revenue CAGR: 0.14% | SUE: -0.66 | # QB: 0
EPS next Year (2026-12-31): EPS=1.52 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-3.1% | Growth Revenue=+8.0%
P/E Forward = 5.3677
P/S = 2.0184
P/B = 0.5883
P/EG = 1.1571
Revenue TTM = 106.4m USD
EBIT TTM = -37.9m USD
EBITDA TTM = 54.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 443.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 435.6m USD (from netDebt column, last quarter)
Enterprise Value = 720.3m USD (284.7m + Debt 443.5m - CCE 7.92m)
Interest Coverage Ratio = -0.99 (Ebit TTM -37.9m / Interest Expense TTM 38.2m)
EV/FCF = 17.01x (Enterprise Value 720.3m / FCF TTM 42.3m)
FCF Yield = 5.88% (FCF TTM 42.3m / Enterprise Value 720.3m)
FCF Margin = 39.80% (FCF TTM 42.3m / Revenue TTM 106.4m)
Net Margin = 51.60% (Net Income TTM 54.9m / Revenue TTM 106.4m)
Gross Margin = 64.10% ((Revenue TTM 106.4m - Cost of Revenue TTM 38.2m) / Revenue TTM)
Gross Margin QoQ = 55.47% (prev 67.10%)
Tobins Q-Ratio = 0.75 (Enterprise Value 720.3m / Total Assets 963.3m)
Interest Expense / Debt = 2.11% (Interest Expense 9.35m / Debt 443.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -29.9m (EBIT -37.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.53 (Total Current Assets 16.0m / Total Current Liabilities 30.3m)
Debt / Equity = 0.91 (Debt 443.5m / totalStockholderEquity, last quarter 489.5m)
Debt / EBITDA = 7.93 (Net Debt 435.6m / EBITDA 54.9m)
Debt / FCF = 10.29 (Net Debt 435.6m / FCF TTM 42.3m)
Total Stockholder Equity = 501.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.39% (Net Income 54.9m / Total Assets 963.3m)
RoE = 10.94% (Net Income TTM 54.9m / Total Stockholder Equity 501.6m)
RoCE = -4.06% (EBIT -37.9m / Capital Employed (Total Assets 963.3m - Current Liab 30.3m))
RoIC = -2.99% (negative operating profit) (NOPAT -29.9m / Invested Capital 1.00b)
WACC = 4.09% (E(284.7m)/V(728.2m) * Re(7.86%) + D(443.5m)/V(728.2m) * Rd(2.11%) * (1-Tc(0.21)))
Discount Rate = 7.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -2.47%
[DCF] Terminal Value 80.82% ; FCFF base≈42.6m ; Y1≈28.0m ; Y5≈12.8m
[DCF] Fair Price = N/A (negative equity: EV 406.5m - Net Debt 435.6m = -29.1m; debt exceeds intrinsic value)
EPS Correlation: -24.25 | EPS CAGR: -42.68% | SUE: -4.0 | # QB: 0
Revenue Correlation: 43.94 | Revenue CAGR: 0.14% | SUE: -0.66 | # QB: 0
EPS next Year (2026-12-31): EPS=1.52 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-3.1% | Growth Revenue=+8.0%